I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 13 studies | 26% ± 8% | |
| CD4-positive, alpha-beta T cell | 12 studies | 21% ± 5% | |
| microglial cell | 12 studies | 61% ± 19% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 9 studies | 21% ± 4% | |
| glutamatergic neuron | 8 studies | 44% ± 22% | |
| natural killer cell | 7 studies | 22% ± 7% | |
| CD8-positive, alpha-beta T cell | 7 studies | 19% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 27% ± 6% | |
| mucosal invariant T cell | 5 studies | 22% ± 5% | |
| T cell | 5 studies | 20% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 19% ± 1% | |
| T follicular helper cell | 4 studies | 21% ± 6% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 23% ± 5% | |
| GABAergic neuron | 3 studies | 26% ± 8% | |
| gamma-delta T cell | 3 studies | 21% ± 1% | |
| mature NK T cell | 3 studies | 24% ± 6% |
